Remdesivir proves effective against COVID-19 in NIAID human clinical trials
Read on UNC News
The Baric Lab at UNC Gillings School of Public Health, in partnership with Gilead Sciences, has found that Remdesivir has been effective in treating patients with COVID-19.
A new antiviral drug heading into clinical trials offers hope for COVID-19 treatment — in part because it can be taken as a pill
Read on Gillings School News
A drug called EIDD-2801 has shown positive outcomes on lung function in mice when used as a prophylactic and as a treatment during infection.